×
We couldn’t find any recent recommendations for this company (matched by symbol or BSE code). Please check back later.
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.09 | 84.8 |
| Triochem Products Ltd., | NA | NA | NA | NA | 0 | |
| SYSCHEM (INDIA) LTD. | NA | NA | NA | NA | 247.0 | 124.0 |
| Lotus Eye Hospital And Institu | 137.04 | 5.45 | 135.17 | 0.26 | 246 | 378.0 |
| AAREY DRUGS & PHARMACEUTICALS | 1037.6 | 13.71 | 1022.08 | 0.48 | 223 | 53.5 |
Syschem (India) Ltd., with Security Code 531173, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 29.5 | 56.9 | 50.3 | 43.7 | 51.5 | 88.0 | 102.2 | 54.2 | 91.1 | 138.7 |
| Expenses | 31.8 | 54.3 | 47.8 | 41.8 | 50.4 | 86.4 | 101.3 | 54.1 | 89.9 | 136.8 |
| Operating Profit | -2.3 | 2.6 | 2.5 | 1.8 | 1.1 | 1.6 | 0.8 | 0.1 | 1.2 | 2.0 |
| OPM % | -7.64% | 4.57% | 4.87% | 4.23% | 2.08% | 1.84% | 0.79% | 0.13% | 1.32% | 1.41% |
| Other Income | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 |
| Interest | 0.1 | 0.0 | 0.1 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Depreciation | 0.7 | 0.6 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.9 |
| Profit before tax | -3.0 | 2.0 | 1.7 | 1.1 | 0.2 | 1.1 | 0.1 | -0.6 | 0.5 | 1.1 |
| Tax % | 0% | -80.8% | 0% | 0% | 0% | -187.3% | 0% | 0% | 0% | -49.4% |
| Net Profit | 2.1 | 0.4 | 1.7 | 1.1 | 0.2 | -1.0 | 0.1 | -0.6 | 0.5 | 0.5 |
| EPS in Rs | 0.67 | 0.53 | 0.35 | 0.06 | -0.07 | 0.03 | -0.16 | 0.13 | 0 |
No Consolidated data available.
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 40% |
| 5 Years: | 34% |
| 3 Years: | 78% |
| TTM: | 67% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 18% |
| 3 Years: | 31% |
| TTM: | -83% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 18% |
| 5 Years: | 49% |
| 3 Years: | 36% |
| 1 Year: | -12% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| 1 Year: | 0% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| News Date ▲▼ | Headline ▲▼ | Issuer Entity ▲▼ | Issuer Type ▲▼ | Order Size ▲▼ | Time Period ▲▼ | |
|---|---|---|---|---|---|---|
| Loading company updates… | ||||||
We couldn’t find any filings or updates in the Company News collection for this BSE code.
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|